MUZAFFAR H QAZILBASH to Immunoglobulin Light-chain Amyloidosis
This is a "connection" page, showing publications MUZAFFAR H QAZILBASH has written about Immunoglobulin Light-chain Amyloidosis.
Connection Strength
1.192
-
Impact of Induction Therapy on the Outcome of Immunoglobulin Light Chain Amyloidosis after Autologous Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2018 11; 24(11):2197-2203.
Score: 0.623
-
Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies. Blood Cancer J. 2023 11 15; 13(1):170.
Score: 0.224
-
A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients. Bone Marrow Transplant. 2022 02; 57(2):295-298.
Score: 0.196
-
Adverse Prognostic Factors for Morbidity and Mortality During Peripheral Blood Stem Cell Mobilization in Patients with Light Chain Amyloidosis. Biol Blood Marrow Transplant. 2018 04; 24(4):815-819.
Score: 0.149